Ly-55A Inhibitors
Ly-55A inhibitors encompass a variety of chemical compounds that function to dampen the activity of Ly-55A, a protein that can be involved in various signaling pathways. Each inhibitor in this class primarily targets and suppresses specific signaling pathways, thereby indirectly decreasing the functional activity of Ly-55A. Compounds such as LY294002, MK-2206, and Wortmannin function by inhibiting PI3K/AKT signaling, a pathway that Ly-55A may be involved in. By suppressing this pathway, these inhibitors can decrease the functional activity of Ly-55A.
Other Ly-55A inhibitors like U0126, PD98059, SP600125, SB203580, BAY 11-7082, Y-27632, PP2, and LY333531 work in a similar manner, disrupting specific signaling pathways and thereby indirectly inhibiting Ly-55A. For instance, U0126 and PD98059 are MEK inhibitors that can disrupt ERK/MAPK signaling, thereby reducing Ly-55A activity is part of this signaling pathway. Similarly, SP600125 is a JNK inhibitor, and by suppressing the JNK pathway, it could indirectly affect the activities of Ly-55A.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that suppresses AKT phosphorylation and downstream signaling, indirectly affecting the function of Ly-55A if it is involved in this pathway. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is an AKT inhibitor that decreases AKT phosphorylation and downstream signaling, potentially impacting Ly-55A if it is part of this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, and by suppressing the JNK pathway, it could indirectly affect the activities of Ly-55A if it is involved in this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, and by suppressing the p38 pathway, it might indirectly affect Ly-55A if it is involved in this pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, a pathway which if Ly-55A is involved in, could result in its decreased functional activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can disrupt AKT signaling, potentially affecting Ly-55A if it is involved in this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can disrupt ERK/MAPK signaling, reducing Ly-55A activity if it is part of this signaling pathway. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
BAY 11-7082 inhibits NF-kB signaling, potentially affecting Ly-55A if it is involved in this pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor which can inhibit Rho/ROCK signaling, potentially causing decreased activity of Ly-55A if it is involved in this pathway. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src inhibitor that can interfere with Src signaling, potentially impacting Ly-55A if it is part of this pathway. | ||||||